Features of indicators of the functional state of the liver, immune link, cytokine regulation and carbohydrate metabolism in patients with toxic chronic diffuse liver diseases

Main Article Content

V.I. Didenko
О.M. Tatarchuk
S.L. Melanich
O.P. Petishko


Background. The problem of the development and progression of chronic diffuse liver diseases is currently one of the most important in modern gastroenterology, it has general medical and social significance. The purpose was to determine the features of indicators of the functional state of the liver, immune link, cytokine regulation and carbohydrate metabolism in patients with alcohol-related and drug-induced chronic diffuse liver diseases. Materials and methods. There were 50 patients with chronic diffuse liver diseases under the supervision: 27 patients with alcoholic liver disease — 16 (59.3 %) men and 11 (40.7 %) women with the ave­rage age of (37.6 ± 2.4) years; and 23 individuals with toxic drug-induced hepatitis — 6 (26.1 %) men and 17 (73.9 %) women aged (49.2 ± 3.1) years. All patients underwent biochemical and immunological blood tests. The levels of interleukin 6 (IL-6), IL-10, tumor necrosis factor α (TNF-α), and the HOMA-IR were also determined. Results. Most patients with alcoholic liver disease and toxic drug-induced hepatitis are characterized by the presence of cytolytic and cholestatic syndromes, mainly of a minimal degree of activity. Signs of hypercoagulation were found 2 times more often among patients with alcoholic liver disease than among those with toxic drug-induced hepatitis (χ2 = 4.43; p < 0.05). In drug-induced liver injury, an increase in the level of prothrombin index was observed 6.5 times more often (χ2 = 10.87; p < 0.01). A significant 1.8-fold decrease in the number of T-killers (p < 0.05) was found in patients with drug-induced liver injury compared to the control group, while in patients with alcoholic liver disease, the activation of the humoral immunity was determined. There was a significant increase in IL-6, TNF-α, the ratio of pro-inflammatory and anti-inflammatory cytokines, the development of insulin resistance in persons with alcohol-related liver damage, while a significant decrease in IL-10 was typical for patients with toxic drug-induced hepatitis. Conclusions. The analysis of the features of the functional state of the liver, immune link, cytokine regulation and carbohydrate metabolism in the examined patients revealed indicators that can be considered laboratory markers for the development and progression of toxic liver lesions.

Article Details

How to Cite
Didenko, V., Tatarchuk О., Melanich, S., & Petishko, O. (2020). Features of indicators of the functional state of the liver, immune link, cytokine regulation and carbohydrate metabolism in patients with toxic chronic diffuse liver diseases. GASTROENTEROLOGY, 54(2), 88–95. https://doi.org/10.22141/2308-2097.54.2.2020.206226
Original Researches


Wong RJ, Gish RG, editors. Clinical Epidemiology of Chronic Live Diseases. Cham, Switzerland: Springer; 2018. 349 р. doi:10.1007/978-3-319-94355-8.

Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis. 2016;20(2):205-214. doi:10.1016/j.cld.2015.10.001.

Goldberg D, Ditah IC, Saeian K, et al. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology. 2017;152(5):1090-1099.e1. doi:10.1053/j.gastro.2017.01.003.

Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113(2):175-194. doi:10.1038/ajg.2017.469.

Yoon YH, Chen CM. Liver cirrhosis mortality in the United States: national, state, and regional trends, 2000-2015: Surveillance Report 105. Arlington, VA: NIAAA; 2015. 70 p.

Marroni CA, Fleck AM Jr, Fernandes SA, et al. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol. 2018;24(26):2785-2805. doi:10.3748/wjg.v24.i26.2785.

Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004;28(9):1347-1355. doi:10.1097/01.alc.0000139815.89794.be.

Wang Y, Fridberg DJ, Leeman RF, Cook RL, Porges EC. Wrist-worn alcohol biosensors: Strengths, limitations, and future directions. Alcohol. 2019;81:83-92. doi:10.1016/j.alcohol.2018.08.013.

Loginov AF, Butorova LI, Loginov VA. Medicinal lesions of the liver: diagnosis, treatment. RMJ. 2016;24(11):721-727. (in Russian).

Polunina TE. Medicinal damage to the liver. RMJ. 2018;26(7-1):7-12 . (in Russian).

Ivashkin VT, Baranovsky AYu, Raikhelson KL, et al. Drug-induced liver injuries (clinical guidelines for physicians). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii. 2019;29(1):85-115. doi:10.22416/1382-4376-2019-29-1-101-131. (in Russian).

Caballería L, Pera G, Arteaga I, et al. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. Clin Gastroenterol Hepatol. 2018;16(7):1138-1145.e5. doi:10.1016/j.cgh.2017.12.048.

Sumerkina VA, Telesheva LF, Golovneva ES, Kvyatkovskaya SV, Dvorchik EE. Lymphocyte subpopulation profile in young men with metabolic syndrome. Meditsinskaya Immunologiya. 2016;18(2):187-191. doi:10.15789/1563-0625-2016-2-187-192. (in Russian).

Tatarchuk OM, Didenko VI, Melanich SL, Kudryavtseva VYe. Immunological reactivity in patients with chronic diffuse liver diseases. Gastroenterologìa. 2018;52(4):222-226. doi:10.22141/2308-2097.52.4.2018.154142. (in Ukrainian).

Mannaa FA, Abdel-Wahhab KG. Physiological potential of cytokines and liver damages. Hepatoma Res 2016;(2):131-143. doi:10.20517/2394-5079.2015.58.

Niederreiter L, Til H. Cytokines and fatty liver diseases. Liver Res.2018;2(1):14-20. doi:10.1016/j.livres.2018.03.003.

Most read articles by the same author(s)

1 2 3 4 5 > >>